Workflow
YONGTAI TECH.(002326)
icon
Search documents
永太科技(002326) - 关于2024年度拟不进行利润分配的公告
2025-04-27 07:45
浙江永太科技股份有限公司(以下简称"公司")于 2025 年 4 月 25 日召开 第六届董事会第二十一次会议及第六届监事会第十二次会议,审议通过了《2024 年度利润分配预案》。本次利润分配预案尚需提交公司 2024 年年度股东大会审议。 现将有关情况公告如下: 一、2024 年度利润分配预案的基本情况 证券代码:002326 证券简称:永太科技 公告编号:2025-028 浙江永太科技股份有限公司 关于 2024 年度拟不进行利润分配的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 经立信会计师事务所(特殊普通合伙)审计,2024 年度公司合并报表实现 归属于上市公司股东的净利润-478,353,981.67 元,2024 年度母公司实现净利润 57,984,325.76 元。根据《公司法》和《公司章程》的有关规定,以母公司净利润 数为基数提取 10%的法定盈余公积金 5,798,432.58 元,加上年初未分配利润 1,340,570,956.93 元,2024 年年末母公司未分配利润为 1,392,756,850.11 元。2024 年年末公司合 ...
永太科技(002326) - 2024 Q4 - 年度财报
2025-04-27 07:41
Financial Performance - The company's operating revenue for 2024 was ¥4,589,397,832.70, representing an increase of 11.18% compared to ¥4,128,040,820.94 in 2023[6]. - The net loss attributable to shareholders for 2024 was ¥478,353,981.67, a 22.82% improvement from a loss of ¥619,761,432.13 in 2023[6]. - The net cash flow from operating activities improved by 66.31%, reaching -¥110,869,010.36 in 2024 compared to -¥329,126,584.00 in 2023[6]. - The basic and diluted earnings per share improved to -¥0.52 in 2024 from -¥0.69 in 2023, reflecting a 24.64% increase[6]. - Total assets decreased by 1.88% to ¥11,190,303,037.06 at the end of 2024 from ¥11,404,306,777.82 at the end of 2023[6]. - The net assets attributable to shareholders decreased by 15.54% to ¥2,671,269,113.39 at the end of 2024 from ¥3,162,895,712.22 at the end of 2023[6]. - The total revenue for 2024 reached ¥4,589,397,832.70, representing an 11.18% increase from ¥4,128,040,820.94 in 2023[67]. - The industrial segment contributed ¥3,184,565,011.65, accounting for 69.39% of total revenue, with a year-on-year growth of 23.55%[67]. - The agricultural protection segment saw a significant increase of 91.79%, generating ¥1,029,494,398.50 in revenue[67]. - The lithium battery and other materials segment reported revenue of ¥1,021,411,381.42, reflecting an 18.07% increase year-on-year[67]. Business Strategy and Operations - The company plans not to distribute cash dividends, issue bonus shares, or increase capital using reserves[4]. - The company aims to expand its international market presence and promote the internationalization of its formulations in the pharmaceutical sector[26]. - The company is focusing on vertical integration from intermediates and raw materials to formulations to enhance profitability and stability in the pharmaceutical segment[26]. - The company plans to optimize its product structure and enhance technological innovation to improve competitiveness in the lithium battery materials sector[25]. - The company has established a vertically integrated industrial chain in the plant protection sector, covering intermediates, raw materials, and formulations, aiming to enhance technical capabilities and reduce costs[27]. - The company is currently constructing projects related to pharmaceutical intermediates, pesticides, and lithium battery materials[94]. - The company has established multiple production bases across regions including Zhejiang, Inner Mongolia, Fujian, and Guangdong to support future core business growth[56]. - The company is actively registering and applying for new products to expand its product portfolio and enhance sales capabilities in the pharmaceutical sector[107]. - The company plans to invest ¥174.43 million in projects in 2024, with a remaining balance of ¥172.48 million in raised funds as of December 31, 2024[102]. Research and Development - The company has multiple innovation technology platforms and a specialized R&D team, holding numerous leading technology patents[51]. - R&D investment totaled 140,378,251.46 CNY, representing 3.06% of total revenue, down from 4.12% in the previous year[81]. - The number of R&D personnel decreased by 11.45% to 464, with a notable increase in the proportion of master's and doctoral degree holders[80]. - The company is currently in the pilot production phase for new lithium battery materials aimed at improving battery performance and stability[80]. - The company has multiple patented technologies, including those for intermediates and pharmaceutical products, enhancing its competitive edge in the market[46]. Environmental Compliance and Sustainability - The company has established a comprehensive environmental protection regulatory framework, regularly updating compliance with applicable laws[176]. - The company is classified as a key pollutant discharge unit by environmental protection authorities[176]. - The company has implemented measures to ensure compliance with major environmental protection laws, including the Environmental Protection Law and the Air Pollution Prevention Law[177]. - The company has a pollution discharge permit for 永太科技 valid until March 28, 2029[178]. - The company has reported a COD discharge of 42.334 mg/L, exceeding the standard limit of 500 mg/L[180]. - The company is actively monitoring and managing its emissions to adhere to environmental regulations[180]. - The company has committed to ongoing compliance with national and local environmental standards to mitigate pollution[181]. - The company invested CNY 92.104 million in environmental governance and protection in 2024, and paid CNY 98,000 in environmental protection tax[193]. Corporate Governance - The company has established a complete governance structure in compliance with relevant laws and regulations, ensuring effective operation and management[122]. - The board of directors consists of 9 members, including 3 independent directors, with 44% of board members being female, including the chairperson and CFO[123]. - The company has a complete and independent financial management system, with dedicated financial personnel and independent accounting practices[128]. - The company actively respects and protects the rights of stakeholders, balancing interests among shareholders, employees, and society[127]. - The company has implemented a diversified policy for its board of directors, considering various factors such as gender, age, and professional experience[123]. - The company ensures timely and accurate information disclosure to all shareholders, providing equal access to information[124]. - The company has established a performance evaluation and incentive mechanism for directors, supervisors, and senior management, ensuring transparency and compliance with regulations[124]. - The company has not experienced any significant discrepancies between its governance practices and the regulations set forth by the China Securities Regulatory Commission[126]. Employee Management - The total number of employees at the end of the reporting period is 3,467, with 933 in the parent company and 2,534 in major subsidiaries[159]. - The employee composition includes 1,673 production personnel, 253 sales personnel, 740 technical personnel, 65 financial personnel, and 736 administrative personnel[159]. - The company has a clear compensation policy linking employee income to performance and capabilities, aimed at motivating staff[160]. - The company has a training program focused on enhancing employees' skills and overall competitiveness to align with its strategic goals[161]. - The company has confirmed that there are no retired employees requiring financial support, indicating a streamlined workforce[159]. Shareholder Relations - The company has established a three-year shareholder return plan (2024-2026) to ensure the continuity and stability of its profit distribution policy[162]. - The company has not received any objections regarding the restricted stock incentive plan from the supervisory board or other stakeholders[165]. - The company completed the registration of the 2024 restricted stock incentive plan, with a total of 11,640,000 shares granted to 302 participants[167]. - The company has a structured remuneration decision-making process based on performance and industry standards[147]. - The company has established a performance assessment mechanism for senior management under the 2024 restricted stock incentive plan, aligning with industry compensation levels and annual operational goals[169].
永太科技(002326) - 2025 Q1 - 季度财报
2025-04-27 07:41
Financial Performance - The company's revenue for Q1 2025 was ¥1,059,959,157.67, representing a year-on-year increase of 28.99% compared to ¥821,748,310.47 in the same period last year[4] - The net profit attributable to shareholders decreased by 45.77% to ¥10,577,472.09 from ¥19,505,595.70 in the previous year[4] - The net profit after deducting non-recurring gains and losses was -¥18,124,603.13, a decline of 226.64% compared to ¥14,311,964.23 in the previous year[4] - The net profit margin decreased by 36.18% due to a decline in overall gross margin[10] - Net profit for the current period was ¥12,844,636.86, a decrease from ¥20,127,848.07, reflecting a decline of approximately 36.0%[21] - Basic earnings per share for the current period were ¥0.011, down from ¥0.021 in the previous period, indicating a decrease of 47.6%[21] Cash Flow - The net cash flow from operating activities improved by 87.65%, reaching -¥18,708,412.05, compared to -¥151,481,243.16 in the same period last year[4] - Operating cash inflow for the current period was CNY 843,466,454.30, an increase of 19.2% from CNY 707,468,894.71 in the previous period[22] - Net cash outflow from operating activities was CNY -18,708,412.05, improving from CNY -151,481,243.16 in the previous period[22] - Cash inflow from financing activities was CNY 1,324,600,729.90, up 32.4% from CNY 1,003,059,836.71 in the previous period[23] - Cash flow from financing activities netted CNY 178,990,666.34, compared to CNY 134,699,899.82 in the previous period, reflecting a 32.8% increase[23] - The company repaid debts totaling CNY 1,102,397,070.19, an increase of 32.9% from CNY 829,441,826.56 in the previous period[23] Assets and Liabilities - The company's total assets decreased by 1.12% to ¥11,065,267,436.50 from ¥11,190,303,037.06 at the end of the previous year[4] - The company's total liabilities decreased to ¥8,176,401,388.16 from ¥8,347,136,924.60, a decline of about 2.0%[18] - Current liabilities increased to ¥6,617,188,077.09 from ¥6,553,420,776.61, showing an increase of approximately 1.0%[18] - Long-term borrowings decreased to ¥1,239,304,325.28 from ¥1,411,479,225.22, a decline of about 12.2%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 116,528, with no preferred shareholders having restored voting rights[12] - The largest shareholder, Wang Yingmei, holds 15.59% of shares, amounting to 144,248,400 shares, with 61,809,999 shares pledged[12] - The top ten shareholders include significant stakes from individuals and companies, with He Renbao holding 12.04% (111,400,000 shares) and Zhejiang Yongtai Holdings Co., Ltd. holding 1.39% (12,887,500 shares)[12] - The total number of shares held by the top ten unrestricted shareholders amounts to 1,263,000,000 shares[12] - The company has a total of 0 preferred shareholders at the end of the reporting period[14] Operational Highlights - The company reported a significant increase in other income by 275.88%, primarily due to increased government subsidies received[9] - The cash flow from investing activities increased by 30.91%, attributed to a reduction in fixed asset investments[11] - The cash flow from financing activities rose by 32.88%, reflecting an increase in net bank borrowings[11] - Research and development expenses rose to ¥26,087,543.36 from ¥22,213,224.82, marking an increase of approximately 17.5%[21] - The company has signed a technology development contract with Fudan University to enhance its core competitiveness in lithium battery materials[14] Inventory and Receivables - Accounts receivable decreased from ¥1,275,457,219.97 to ¥1,196,000,723.70, representing a reduction of about 6.2%[16] - Inventory increased from ¥987,727,619.21 to ¥1,124,553,506.64, reflecting a growth of approximately 13.8%[16] - The company's cash and cash equivalents decreased from ¥739,281,281.26 to ¥594,745,420.50, a decline of approximately 19.5%[16]
永太科技(002326) - 关于控股股东部分股权解除质押的公告
2025-04-09 08:30
证券代码:002326 证券简称:永太科技 公告编号:2025-025 浙江永太科技股份有限公司 关于控股股东部分股权解除质押的公告 | 股东 | 是否为第一大股 | 本次解除质押 | 本次解除质押占其 | 占公司总股 | 质押 | 质押 | 质权人 | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 东及一致行动人 | 股数(万股) | 所持股份比例(%) | 本比例(%) | 开始日期 | 解除日期 | | | 王莺妹 | 是 | 771.00 | 5.34 | 0.83 | 2024-10-29 | 2025-04-08 | 上海海通证券资 产管理有限公司 | 二、股东股份累计质押情况 截至公告披露日,上述股东及其一致行动人所持质押股份情况如下: | | | | 本次解除质 | 本次解除质 | 占其所 | 占公司 | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 持股数量 | 持股比 | ...
浙江永太科技股份有限公司关于 全资子公司完成工商变更登记的公告
登录新浪财经APP 搜索【信披】查看更多考评等级 经临海市市场监督管理局核准,永太手心、永太药业、永太新能源已于近日办理完成工商变更登记手续 并取得新的《营业执照》,具体变更情况如下: ■ 除上述变更外,其余登记事项不变。 特此公告。 证券代码:002326 证券简称:永太科技 公告编号:2025-023 浙江永太科技股份有限公司关于 全资子公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 基于业务发展需要,浙江永太科技股份有限公司(以下简称"公司")以自有资金分别向全资子公司浙江 永太手心医药科技有限公司(以下简称"永太手心")和浙江永太药业有限公司(以下简称"永太药业") 增加注册资本20,000万元和10,000万元。公司全资子公司浙江永太新能源材料有限公司(以下简称"永太 新能源")因业务拓展需求,对经营范围进行变更。 根据《公司章程》的相关规定,本次全资子公司增加注册资本和变更经营范围均在公司董事长决策权限 范围内,无需提交董事会和股东大会审议批准。 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误 ...
永太科技(002326) - 关于全资子公司完成工商变更登记的公告
2025-04-08 08:30
证券代码:002326 证券简称:永太科技 公告编号:2025-023 浙江永太科技股份有限公司 经临海市市场监督管理局核准,永太手心、永太药业、永太新能源已于近 日办理完成工商变更登记手续并取得新的《营业执照》,具体变更情况如下: | 公司 | 变更事项 | 变更前 | 变更后 | | --- | --- | --- | --- | | 永太手心 | 注册资本 | 贰亿元整 | 肆亿元整 | | 永太药业 | 注册资本 | 叁亿元整 | 肆亿元整 | | 永太新能源 | 经营范围 | | 一般项目:电子专用材料制 | | | | 一般项目:电子专用材料制 | 造;基础化学原料制造(不含 | | | | 造;基础化学原料制造(不含 | 危险化学品等许可类化学品的 | | | | 危险化学品等许可类化学品的 | 制造);货物进出口;金属材 | | | | 制造);货物进出口(除依法 | 料销售;化工产品销售(不含 | | | | 须经批准的项目外,凭营业执 | 许可类化工产品)(除依法须 | | | | 照依法自主开展经营活动)。 | 经批准的项目外,凭营业执照 | | | | | 依法自主开展经营活动)。 | ...
永太科技(002326) - 关于公司银行账户解除冻结的公告
2025-04-08 08:30
截至本公告披露日,上述买卖合同纠纷事宜约定的相关事项均已实施完毕。 公司近日通过查询银行账户获悉,公司银行募集资金专户剩余被冻结资金已全部 解除冻结,具体情况如下: 证券代码:002326 证券简称:永太科技 公告编号:2025-024 浙江永太科技股份有限公司 关于公司银行账户解除冻结的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 浙江永太科技股份有限公司(以下简称"公司")与肥东国轩新材料有限公 司因买卖合同纠纷事宜,双方各自向法院提起诉讼,并实施了财产保全措施。一 审判决后,双方均未上诉并达成了和解,在一审判决的基础上对款项结算、双方 资产解封等事项进行了具体约定,并按照约定逐步实施。具体内容详见公司于 2023 年 12 月 19 日披露的《关于公司诉讼事项的公告》《关于公司部分银行账 户被冻结的公告》,2024 年 1 月 9 日披露的《关于公司收到民事起诉状的公告》, 2024 年 12 月 31 日披露的《关于诉讼事项的进展公告》,2025 年 1 月 24 日披露 的《关于公司诉讼事项的进展及部分银行账户解除冻结的公告》,2025 年 ...
浙江永太科技股份有限公司关于控股股东部分股权质押的公告
截至公告披露日,上述股东及其一致行动人所持质押股份情况如下: 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002326 证券简称:永太科技 公告编号:2025-021 浙江永太科技股份有限公司 关于控股股东部分股权质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 浙江永太科技股份有限公司(以下简称"公司")近日接到控股股东王莺妹女士的通知,获悉王莺妹女士 将其持有的本公司部分股权质押。具体事项如下: 一、股东股份本次质押基本情况 ■ 二、股东股份累计质押情况 ■ 注:本公告中所述限售股不包括高管锁定股。 三、其他情况说明 公司控股股东及其一致行动人资信状况良好,具备良好的资金偿还能力,目前不存在可能引发平仓风险 或导致本公司实际控制权发生变更的实质性因素。如后续出现风险,公司控股股东及其一致行动人将采 取包括但不限于补充质押、提前还款等措施加以应对。公司将持续关注其质押情况及质押风险情况,将 严格遵守相关规定,及时履行信息披露义务。 四、备查文件 中国证券登记结算有限责任公司质押明细表。 特此公告。 浙江永太科技股份有限公司 董 事 ...
永太科技(002326) - 关于全资子公司完成工商变更登记的公告
2025-04-07 11:45
浙江永太科技股份有限公司(以下简称"公司")于2025年4月2日召开第六 届董事会第二十次会议,审议通过了《关于增加全资子公司注册资本的议案》, 因全资子公司内蒙古永太化学有限公司(以下简称"内蒙古永太")业务发展需 要,同意公司以自有资金向内蒙古永太增加注册资本60,000万元。具体内容详见 公司于2025年4月4日披露的《关于增加全资子公司注册资本的公告》(公告编号: 2025-019)。 经乌海市海南区市场监督管理局核准,公司已于近日办理完成增加注册资本 工商变更登记手续,并取得新的《营业执照》,具体变更情况如下: 证券代码:002326 证券简称:永太科技 公告编号:2025-022 浙江永太科技股份有限公司 关于全资子公司完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 变更前注册资本:陆亿玖仟壹佰万元(人民币元) 变更后注册资本:壹拾贰亿玖仟壹佰万元(人民币元) 其余登记事项不变。 特此公告。 浙江永太科技股份有限公司 董 事 会 2025 年 4 月 8 日 ...
永太科技(002326) - 关于控股股东部分股权质押的公告
2025-04-07 11:45
证券代码:002326 证券简称:永太科技 公告编号:2025-021 浙江永太科技股份有限公司 关于控股股东部分股权质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 浙江永太科技股份有限公司(以下简称"公司")近日接到控股股东王莺妹 女士的通知,获悉王莺妹女士将其持有的本公司部分股权质押。具体事项如下: 二、股东股份累计质押情况 截至公告披露日,上述股东及其一致行动人所持质押股份情况如下: 浙江永太科技股份有限公司 | | | | | | 占其所 | 占公司 | 已质押股份情况 | | 未质押股份情况 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 持股数量 | 持股比 | 本次质押前 | 本次质押后 | 持股份 | 总股本 | 已质押股份 | 占已质 | 未质押股 | 占未质 | | 名称 | (万股) | 例(%) | 质押股份数 | 质押股份数 | 比例 | 比例 | 限售和冻结 | 押股份 | 份限售和 | 押股份 | | | | ...